Rchr
J-GLOBAL ID：202101000458776745   Update date: Jan. 30, 2024

Kudo Ikuru

Kudo Ikuru
Research theme for competitive and other funds  (2)：
  • 2021 - 2024 メトホルミンとファスティング併用による腫瘍微小環境改変に関する研究
  • 2019 - 2023 メトホルミンと抗PD-1抗体併用療法の発展:多重蛍光組織染色で解く腫瘍微小環境
Papers (2)：
  • Ruoyu Chao, Mikako Nishida, Nahoko Yamashita, Miho Tokumasu, Weiyang Zhao, Ikuru Kudo, Heiichiro Udono. Nutrient Condition in the Microenvironment Determines Essential Metabolisms of CD8+ T Cells for Enhanced IFNγ Production by Metformin. Frontiers in Immunology. 2022. 13
  • Miho Tokumasu, Mikako Nishida, Takamasa Kawaguchi, Ikuru Kudo, Tohru Kotani, Kazuhiko Takeda, Takao Yoshida, Heiichiro Udono. Blocking EP4 down-regulates tumor metabolism and synergizes with anti-PD-1 therapy to activate natural killer cells in a lung adenocarcinoma model. International Immunology. 2022. 34. 6. 293-302
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page

TOP

BOTTOM